65,437 trials
Communication · Pain
Primary: Percentage of Eligible Patients Enrolled — 18; 18 Participants
CMV · Congenital Cmv · Maternal Infections Affecting Fetus or Newborn
Primary: The Prevalence of CMV Shedding in Saliva, Urine and Vaginal Secretions of CMV Seropositive Women in Pregnancy — 27; 4; 16; 20 Participants
Language Development Disorders · Down Syndrome · Child Language
Primary: Accuracy Identifying Taught Words - Syntactic Condition — 8.73; 8.75; 10.29 Score on a scale — p=0.73
Cigarette Smoking
Primary: Combustible Cigarette Cessation — 1; 4 Participants
NASH - Nonalcoholic Steatohepatitis
Primary: Patient Incidence of Adverse Events for TERN-201 Versus Placebo — 9; 11; 8 Participants
Cancer, Breast · Alzheimer Disease
Primary: Decisional Conflict Scale — -1.9; -0.8 Units on DCS scale — p=0.4393
Pulmonary Hypertension Secondary · Heart Failure
Primary: Mean Pulmonary Artery Pressure (mPAP) During Submaximal Exercise as Compared Between Placebo and Nitrite — 48.75; 48.68; 56.81; 55.0 mmHg — p=0.20
Alcohol Use Disorder · Alcoholism · Alcohol Dependence
Primary: Alcohol Consumption as Measured by Phosphatidylethanol (PEth) in Blood — -0.406; -0.417; -0.315; 0.250 mikromol/litre
Depressive Symptoms · Depression · Adolescent Behavior
Primary: Mean Score of Depressive Symptoms — -9.50; -8.30 score on a scale
Breast Cancer
Primary: Missed Fractions
Abnormal Glucose Tolerance · Type 1 Diabetes
Primary: Time From Randomization to Confirmed Abnormal Glucose Tolerance Test — 89.2; 71.6 months
Alzheimer Disease
Primary: Return to Baseline Physical Function Based on the Barthel Index (Change From 2 Weeks Prior to Admission and Changes at Admission, Discharge, and 2 and 6 Months…
Cataract
Primary: Total Lens Removal Time — 76.0; 80.1 seconds
Central Nervous System Infections · Pseudotumor Cerebri · Neurological Disorder
Primary: Number of Insertion Attempts — 1.8; 2.2; 1.2; 2.1 insertions
Obesity
Primary: Body Weight (kg) — 104.46; 104.23 kilograms — p=.804